“…while formula‐fed infants have a higher diversity and increased levels of Escherichia coli , Clostridium difficile , Bacteroides fragilis , and Lactobacilli (Backhed et al, ; Bezirtzoglou, Tsiotsias, & Welling, ; Favier, Vaughan, De Vos, & Akkermans, ; Penders et al, ). Even though the intestinal microbiota diversity is significantly lower (Backhed et al, ; Thompson, Monteagudo‐Mera, Cadenas, Lampl, & Azcarate‐Peril, ), in breastfed infants, their microbial communities interact significantly more with host genes compared with formula‐fed infants, and their transcriptomic activities are more associated with immune response and metabolic activities (Praveen, Jordan, Priami, & Morine, ; Schwartz et al, ). For example, there is enrichment for anti‐inflammatory genes and genes required for the utilization of human milk oligosaccharides (HMOs) from breastmilk in breastfed infant host epithelial cells (Schwartz et al, ).Utilization of different HMOs, for example, fucosylated oligosaccharides, can promote the growth of Bifidobacterium longum and several species of Bacteroides leading to a transition from proinflammatory bacteria such as E. coli and Clostridium perfringens (Marcobal et al, ; Yu et al, ).…”